Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation Expense

v3.23.3
Stock-Based Compensation Expense
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Expense Stock-Based Compensation Expense
The Company granted the following equity instruments during the three and nine months ended September 30, 2023 and 2022, respectively (in thousands of units):
Three Months Ended September 30, Nine Months Ended September 30,
2023 2022 2023 2022
Options Granted —  —  187  — 
RSUs Granted 185  190  1,188  888 

The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022, respectively (in thousands):
Three Months Ended September 30, Nine Months Ended September 30,
2023 2022 2023 2022
General and administrative $ 4,710  $ (13,768) $ 16,767  $ 69,343 
Sales and marketing 34  560  250  2,026 
Research and development (509) 2,892  419  10,669 
Total(1)
$ 4,235  $ (10,316) $ 17,436  $ 82,038 
(1) Included in stock-based compensation are total reversals of $5.5 million and $9.7 million for the three and nine months ended September 30, 2023, respectively (2022 - $32.0 million and $33.1 million) as a result of forfeitures.